Skin permeation of acyl derivatives of stobadine

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 13, Issue 1, 2006, Pages 51-54

  Májeková, Magdaléna ^a   Koprda, Vasil ^b   Boháčik, L'ubor ^a   Bohov, Pavol ^c   Hadgraft, Jonathan ^d   Bezáková, Zelmíra ^e   Májek, Pavol ^b  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^c INSTITUTE OF EXPERIMENTAL ENDOCRINOLOGY   (Slovakia)

^d UNIVERSITY OF LONDON   (United Kingdom)

^e Physics and Informatics   (Slovakia)

Author keywords

Partition Coefficient; Permeation; pKa; Prodrug; Quantum Chemical Calculation; Stobadine

Indexed keywords

N ACETYLSTOBADINE; PRODRUG; STOBADINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CALCULATION; DISSOCIATION CONSTANT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG STRUCTURE; DRUG TRANSPORT; FRAGMENTATION REACTION; NONHUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUANTUM CHEMISTRY; SKIN PENETRATION; THEORETICAL STUDY;

ACYLATION; ADMINISTRATION, CUTANEOUS; ALGORITHMS; ANIMALS; CARBOLINES; CHEMISTRY, PHYSICAL; CHROMATOGRAPHY, ION EXCHANGE; PERMEABILITY; RATS; SKIN ABSORPTION;

EID: 30644477341     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540500313729     Document Type: Article

References (14)

1. AMSOL 6.9. 2003. University of Minnesota, Minneapolis, MN, USA.
2. Beneš, L., and Pronayová, N. 1994. Free radical scavenger prodrugs - potentially potent brain penetrating agents. Pharmazie 49:69-70.
3. Beneš, L., and Štolc, S. 1989. Stobadine. Drugs of the Future 14:135-137.
4. Bezáková, Ž., Blešová, M., and Bachratá, M. 1993. [Stobadine-dihydrochloride - study of physicho-chemical properties and stability]. Farm. Obzor 62:247-252. In Slovak.
5. Dewar, M. J. S., Zoebish, E. G., Healy, E. F., and Stewart, J. J. P. 1985. AM1: a new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 107:3902-3909.
6. Ghose, A. K., Pritchett, A., and Crippen, G. M. 1988. Atomic physicochemical parameters for three-dimensional structure directed quantitative structure-activity relationships III: modelling hydrophobic interactions. J. Comput. Chem. 9:80-90.
7. HyperChem 7.0 for Windows. 2003. Hypercube, Inc.
8. International symposium: Drug action on reactive oxygen species with special attention to stobadine. 1999. Life Sci. 65:1857-2015.
9. Koprda, V., Boháčik, L'., Bohov, P., and Hadgraft, J. 1996. Skin permeation of stobadine acyl derivatives. In Prediction of Percutaneous Penetration, ed. Brain, K. R., James, V. J., and Walters, K. A., vol. 4a, 1995, C26;
10. Koprda, V., Boháčik, L'., Bohov, P., and Hadgraft, J. In Prediction of Percutaneous Penetration, Vol.4b, 93-96. Cardiff: STS Publishing Ltd.
11. Kubinyi, H. 1977. Quantitative structure-activity relationships. 7. The bilinear model, a new model for nonlinear dependence of biological activity on hydrophobic character. J. Med. Chem. 20:625-629.
12. Ondrášová, M., Stankovičová, M., Bezáková, Ž., and Beneš, L. 2000. [Kinetics of hydrolysis of acylderivatives of stobadine, prodrug forms of free oxygen radical scavengers. Part 2: alkaline hydrolysis]. Česk/Slov. Farm. 49(5):251-255. In Slovak.
13. Štolc, S., Bauer, V., Beneš, L., and Tichý, M. 1985. Swiss patent 651754.
14. Viswanadham, V. N., Ghose, A. K., Revankar, G. N., and Robins, R. K. 1989. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 29:163-172.